Literature DB >> 22063385

Antigenic distance measurements for seasonal influenza vaccine selection.

Zhipeng Cai1, Tong Zhang, Xiu-Feng Wan.   

Abstract

Influenza vaccination is one of the major options to counteract the effects of influenza diseases. Selection of an effective vaccine strain is the key to the success of an effective vaccination program since vaccine protection can only be achieved when the selected influenza vaccine strain matches the antigenic variants causing future outbreaks. Identification of an antigenic variant is the first step to determine whether vaccine strain needs to be updated. Antigenic distance derived from immunological assays, such as hemagglutination inhibition, is commonly used to measure the antigenic closeness between circulating strains and the current influenza vaccine strain. Thus, consensus on an explicit and robust antigenic distance measurement is critical in influenza surveillance. Based on the current seasonal influenza surveillance procedure, we propose and compare three antigenic distance measurements, including Average antigenic distance (A-distance), Mutual antigenic distance (M-distance), and Largest antigenic distance (L-distance). With the assistance of influenza antigenic cartography, our simulation results demonstrated that M-distance is a robust influenza antigenic distance measurement. Experimental results on both simulation and seasonal influenza surveillance data demonstrate that M-distance can be effectively utilized in influenza vaccine strain selection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22063385      PMCID: PMC3246038          DOI: 10.1016/j.vaccine.2011.10.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 3.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Authors:  Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

4.  A computational framework for influenza antigenic cartography.

Authors:  Zhipeng Cai; Tong Zhang; Xiu-Feng Wan
Journal:  PLoS Comput Biol       Date:  2010-10-07       Impact factor: 4.475

5.  Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test.

Authors:  A S Monto; H F Maassab
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

6.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

7.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

Authors:  A L Frank; J Puck; B J Hughes; T R Cate
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus.

Authors:  Yuri I Wolf; Cecile Viboud; Edward C Holmes; Eugene V Koonin; David J Lipman
Journal:  Biol Direct       Date:  2006-10-26       Impact factor: 4.540

9.  Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1).

Authors: 
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

10.  The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.

Authors:  Karoline Bragstad; Lars P Nielsen; Anders Fomsgaard
Journal:  Virol J       Date:  2008-03-07       Impact factor: 4.099

View more
  10 in total

1.  Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Authors:  Yang Li; David L Bostick; Colleen B Sullivan; Jaclyn L Myers; Sara B Griesemer; Kirsten Stgeorge; Joshua B Plotkin; Scott E Hensley
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 2.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

3.  Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.

Authors:  Martina Kosikova; Lei Li; Peter Radvak; Zhiping Ye; Xiu-Feng Wan; Hang Xie
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

4.  Measuring Site-specific Glycosylation Similarity between Influenza a Virus Variants with Statistical Certainty.

Authors:  Deborah Chang; William E Hackett; Lei Zhong; Xiu-Feng Wan; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2020-06-29       Impact factor: 5.911

5.  Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.

Authors:  Kara McCormick; Zhiyong Jiang; Longchao Zhu; Steven R Lawson; Robert Langenhorst; Russell Ransburgh; Colin Brunick; Miranda C Tracy; Heather R Hurtig; Leah M Mabee; Mark Mingo; Yanhua Li; Richard J Webby; Victor C Huber; Ying Fang
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

6.  Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates.

Authors:  Christopher S Anderson; Marta L DeDiego; Juilee Thakar; David J Topham
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

7.  R0: Host Longevity Matters.

Authors:  L M Viljoen; L Hemerik; J Molenaar
Journal:  Acta Biotheor       Date:  2018-02-19       Impact factor: 1.774

8.  Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.

Authors:  Christopher S Anderson; Patrick R McCall; Harry A Stern; Hongmei Yang; David J Topham
Journal:  BMC Bioinformatics       Date:  2018-02-12       Impact factor: 3.169

Review 9.  Antigenic characterization of influenza and SARS-CoV-2 viruses.

Authors:  Yang Wang; Cynthia Y Tang; Xiu-Feng Wan
Journal:  Anal Bioanal Chem       Date:  2021-12-14       Impact factor: 4.142

10.  Trends in Excess Winter Mortality (EWM) from 1900/01 to 2019/20-Evidence for a Complex System of Multiple Long-Term Trends.

Authors:  Rodney P Jones; Andriy Ponomarenko
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.